The Impact of Image Reconstruction Parameters on TARE Treatment Dosimetric Calculation
Open Access
- 28 June 2024
- journal article
- research article
- Published by Celal Bayar University Journal of Science in Celal Bayar Üniversitesi Fen Bilimleri Dergisi
- Vol. 20 (2) , 45-53
Abstract
Accurate dosimetric calculations are essential to enhance therapeutic efficacy in Yttrium-90 (Y-90) microsphere therapy, which rely significantly on the three-dimensional imaging parameters used. This study aims to evaluate the reconstruction parameters used to generate three-dimensional images from SPECT data obtained for dosimetric calculations, and to determine the optimal reconstruction parameters. This retrospective study evaluated Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) images of 30 patients (8 women and 22 men) who underwent Transarterial Radioembolization (TARE) treatment at our clinic between 2018 and 2019 using Technetium 99mTc-labeled macroaggregated albumin (99mTc-MAA). The SPECT images were reconstructed using 20 different iterations and subset values. The perfused areas were identified using 5% and 10% threshold values. At the 5% threshold, the maximum difference from the average was 20.7% at 2 iterations and 2 subsets. For other parameters, the difference from the average was less than 2.8%. At the 10% threshold, the maximum difference from the average was 14.8% at 2 iterations and 2 subsets, with other parameters again showing a difference of less than 2.8%. For effective TARE treatment, it is recommended to set the SPECT image reconstruction parameters to higher than 5 iterations and 5 subsets following the administration of 99mTc-MAA.Keywords
This publication has 20 references indexed in Scilit:
- Influence of Early Versus Delayed Hepatic Artery Perfusion Scan on 90 Y Selective Internal Radiation Therapy PlanningCancer Biotherapy and Radiopharmaceuticals, 2024
- Use of dose–volume histograms for metabolic response prediction in hepatocellular carcinoma patients undergoing transarterial radioembolization with Y-90 resin microspheresAnnals of Nuclear Medicine, 2024
- Influencing factors of lung shunt fraction in transarterial radioembolization treatmentClinical and Translational Imaging, 2023
- AAPM Medical Physics Practice Guideline 14.a: Yttrium‐90 microsphere radioembolizationJournal of Applied Clinical Medical Physics, 2023
- Yttrium-90 Radiation Segmentectomy of Hepatocellular Carcinoma: A Comparative Study of the Effectiveness, Safety, and Dosimetry of Glass-Based versus Resin-Based MicrospheresJournal of Vascular and Interventional Radiology, 2023
- A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- TARE in Hepatocellular Carcinoma: From the Right to the Left of BCLCCardioVascular and Interventional Radiology, 2022
- EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compoundsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Y90 selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not?Nuclear Medicine Communications, 2020
- Transarterial Radioembolization for Hepatocellular Carcinoma and Hepatic Metastases: Clinical Aspects and Dosimetry ModelsSeminars in Radiation Oncology, 2020